Enthusia

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Enthusia

Property Description
Active ingredient Sildenafil (usually as Sildenafil Citrate)
Form Film-coated tablet (Oral dosage form)
Pharmacological class Selective Phosphodiesterase type 5 (PDE5) inhibitor
Common use Supports physiological functions dependent on local blood flow
Origin Synthetic chemical compound

Enthusia is a prescription-only medicinal product defined by its active chemical substance and its specific pharmacological classification, established as a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). This classification denotes a systemic agent that works by targeting a single, specific enzyme within the body’s signaling pathways, placing it within the hierarchy of modern vascular therapeutics.


What is Enthusia and its Pharmacological Class?

Enthusia is a pharmaceutical preparation whose active ingredient is Sildenafil, belonging to the class of selective Phosphodiesterase type 5 (PDE5) inhibitors. Sildenafil is formally classified as a PDE5 inhibitor. This confirms its mechanism of action is limited to inhibiting the PDE5 enzyme. This mechanism is clinically recognized for its role in managing conditions where augmented blood flow is physiologically beneficial. This differentiating factor from less selective vascular drugs makes it a key therapeutic option for targeted circulatory support.


Sildenafil: Composition, Origin, and General Purpose

The core composition of Enthusia is the synthetic chemical compound Sildenafil, typically present as Sildenafil Citrate, which is manufactured through synthesis processes rather than being extracted from natural sources. Enthusia is administered as an oral dosage form, specifically a film-coated tablet. The active compound's function is centered on preventing the rapid breakdown of cGMP (cyclic guanosine monophosphate), a key molecule that signals the smooth muscles surrounding certain blood vessels to relax. The resultant accumulation of cGMP facilitates this smooth muscle relaxation, leading to increased local blood flow. The general purpose of Enthusia is therefore to support and enhance physiological responses dependent on sustained local circulation, such as in instances requiring improved vascular response.

What side effects are possible with Enthusia?

Possible side effects and safety information

The safety profile of Enthusia (Sildenafil) is structured by regulatory bodies based on its documented adverse reactions and specific safety constraints. These effects are classified by how often they occur, following standards used in official prescribing information.

Frequency-Classified Adverse Reactions

Classification Examples of Officially Documented Effects
Very Common (Occurs in ge 1 in 10 patients) Headache
Common (Occurs in ge 1 in 100 patients) Flushing, Dyspepsia (indigestion), Abnormal Vision (including color tinge), Nasal Congestion, Dizziness
Uncommon to Rare Rash, Myalgia (muscle pain), Back Pain, Epistaxis (nosebleeds), Vomiting

Adverse reactions are also categorized by the System-Organ Class affected, including Nervous System, Vascular Disorders, Eye Disorders, and Gastrointestinal Disorders, reflecting the drug’s physiological action.

Serious Adverse Reactions and Safety Constraints

The official safety information highlights certain reactions that are rare but clinically significant. These serious adverse reactions include Priapism (a prolonged erection), sudden decrease or loss of hearing, and a specific type of sudden vision loss (Non-arteritic Anterior Ischaemic Optic Neuropathy, or NAION). Serious cardiovascular events, such as myocardial infarction or stroke, have also been reported in temporal association with use.

Safety is further constrained by specific warnings regarding pre-existing conditions. Enthusia is contraindicated for individuals taking any form of organic nitrates or Guanylate Cyclase Stimulators. Specific safety considerations are also noted for patients with severe hepatic or renal impairment or those with certain conditions predisposing them to priapism.

Overdose and Emergency Response

Overdose and When to Seek Help

Overexposure to Enthusia (Sildenafil) is officially documented to increase the incidence and severity of reported effects. Manifestations listed in regulatory labeling include dose-dependent increases in headache, flushing, dyspepsia, and dizziness, alongside decreased blood pressure (hypotension) and abnormal vision. Acute vascular and cerebrovascular events, such as myocardial infarction and stroke, have been reported in post-marketing surveillance.

Immediate Regulatory Actions

Regulatory authorities mandate seeking medical help for specific severe outcomes:

Condition Required Action
Prolonged Erection (> 4 hours) Seek immediate medical attention
Sudden Loss of Vision Seek immediate medical attention
Sudden Loss of Hearing Seek prompt medical attention

Management and Risk Considerations

Overdose management relies on symptomatic treatment and general supportive measures, as the official prescribing information states that no specific antidote is known. The drug’s high protein binding indicates that procedural clearance measures, such as renal dialysis, are not anticipated to be effective. Patients with severe hepatic or renal impairment are noted to have reduced drug clearance, leading to an increased risk of elevated systemic exposure in the event of overdosage.

Therapeutic Uses of Enthusia

What Enthusia Treats: Main Uses and Benefits

Enthusia (Sildenafil) is commonly used across two primary therapeutic domains where additional symptomatic support is needed to address symptoms linked to organ-specific functional stress.

Enthusia is applied in conditions where functional stability becomes affected, such as is relevant for easing symptoms related to Erectile Dysfunction (ED), and it is commonly used to help with symptoms related to Pulmonary Arterial Hypertension (PAH). The medication may assist with managing symptoms related to physical discomfort, whether it is the difficulty in maintaining an erection or the shortness of breath and fatigue associated with the lung condition.

“The treatment may assist with managing symptoms that create noticeable physiological strain, supporting improved comfort during symptomatic periods.”

It is applied in clinical settings that involve acute or unstable symptom patterns, such as ED secondary to diabetes or post-surgical status. The supportive relief provided may help patients cope more steadily with symptom fluctuations.


Quick Fact: Relief for Functional Strain

Enthusia may play a role in managing symptoms of two main conditions: Erectile Dysfunction and Pulmonary Arterial Hypertension, by easing distress. It may help address symptom clusters that interfere with daily comfort.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Enthusia

Official regulatory documents define strict eligibility criteria for the use of Enthusia (Sildenafil). The medicine is primarily indicated for adult men with Erectile Dysfunction (ED) and adults and pediatric patients (ages 1–17) for Pulmonary Arterial Hypertension (PAH).

Classification Populations
Absolute Contraindication Patients using organic nitrates or guanylate cyclase stimulators [Source 1.1]. Patients with known hypersensitivity to the active ingredient [Source 1.2]. Patients with a history of vision loss due to NAION [Source 1.2] or severe hepatic impairment [Source 2.4].
Conditional Use Patients with severe renal impairment or hepatic impairment (mild to moderate) require consideration for a lower starting dose due to reduced clearance [Source 2.7]. Use is restricted or not recommended in patients with a recent history of stroke or myocardial infarction [Source 2.6] or those with severe hypotension [Source 2.4].
Age-Related Rules The ED indication is not indicated for women or individuals under 18 years of age [Source 2.7]. For the PAH indication, chronic use is not recommended in pediatric patients due to reports of increased mortality with higher doses [Source 1.2].

The official profile structures who can and cannot use the medicine by defining mandatory exclusions and restrictions based on co-medication status, cardiovascular stability, and organ function, all of which must be assessed against labeled guidelines.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Certain substance combinations with Enthusia (Sildenafil) are documented in regulatory labeling due to the risk of significant interaction, requiring either prohibition or specific restrictions.


Prohibited Combinations and Restrictions

Co-administration with Organic Nitrates (e.g., nitroglycerin) is strictly contraindicated. This combination is prohibited because the drugs produce an additive pharmacological effect, which may lead to severe hypotension. Similarly, co-administration with the Guanylate Cyclase Stimulator Riociguat is also formally contraindicated due to the risk of symptomatic low blood pressure. Regulatory documentation advises against combining Enthusia with any other PDE5 inhibitors.


Effects on Drug Clearance

Enthusia's systemic clearance is primarily mediated by the CYP3A4 liver enzyme. Substances that act as strong inhibitors of this enzyme, such as Ritonavir, Ketoconazole, and Itraconazole, cause a substantial increase in Sildenafil plasma concentrations and reduced clearance. Due to this pharmacokinetic interaction, a maximum dose restriction and a mandatory 48-hour time separation are required when co-administering with Ritonavir. Strong CYP3A4 inducers like Rifampicin may conversely decrease exposure.


Other Documented Interactions

The combination with Alpha-blockers carries a risk of additive blood pressure lowering effects. Grapefruit Juice may slightly increase systemic exposure due to minor enzyme inhibition. In patients being treated for Pulmonary Arterial Hypertension, co-administration with Oral Vitamin K Antagonists (e.g., Warfarin) has been associated with a higher incidence of epistaxis.

Mechanism of Action

How Enthusia Works: Mechanism of Action

Selective Enzyme Inhibition and Signal Preservation

Enthusia's active ingredient acts as a selective inhibitor of the enzyme Phosphodiesterase type 5 (PDE5), which is primarily responsible for the rapid breakdown of the intracellular messenger, cGMP. By blocking this enzyme, the mechanism reduces the rate of signal termination, leading to the preservation and accumulation of cGMP within the target cells.


The NO-cGMP Cascade and Smooth Muscle Relaxation

The accumulated cGMP supports the continuation of the natural Nitric Oxide (NO) signaling pathway, initiating a molecular cascade that reduces intracellular calcium levels in the local vascular smooth muscle cells. This reduction triggers vasorelaxation (muscle relaxation), which physically translates into an increase in the caliber of the blood vessels and thus increased local tissue perfusion.


Functional Limits and Dependence on Local Stimuli

Crucially, this mechanism is dependent on the local release of Nitric Oxide from nearby cells; Enthusia only preserves the cGMP molecule but cannot generate it. Therefore, the physiological effect of increased blood flow is only realized in response to the relevant upstream biological stimuli, making the mechanism one of signal modulation rather than spontaneous activity.

Dosage and Administration Information

How to Use Enthusia

The usage of Enthusia (Sildenafil) is governed by protocols that define the appropriate route, dose, and frequency, dependent on the patient's specific indication. The medicine is officially administered through two routes: Oral (as a film-coated tablet or reconstituted suspension) and Intravenous (IV) Bolus Injection.


Dosing and Frequency Patterns

Administration follows two contrasting temporal patterns:

  • Intermittent Use (Erectile Dysfunction): The starting oral dose is typically 50 mg, adjustable from 25 mg to a maximum of 100 mg. It is taken as needed, approximately one hour prior to activity, with administration strictly limited to once per day.
  • Scheduled Use (Pulmonary Arterial Hypertension): The standard oral dose is 20 mg, administered on a scheduled basis three times daily (TID). The IV dose is 10 mg when oral intake is not feasible.

Administration Conditions and Limits

Tablets can be taken with or without food; however, consuming the dose with a high-fat meal may result in a delayed onset of activity. Specific dose adjustments are required for certain patient groups. A 25 mg starting dose for the intermittent-use indication is standard for patients with severe hepatic or renal impairment. The intravenous formulation is intended for temporary use and must be administered as a slow bolus injection over a designated time period.

Recent Clinical Evidence

Enthusia: Recent Clinical Evidence

This section outlines the research that has evaluated patient outcomes associated with Enthusia. The information below is strictly descriptive of study findings and is not a substitute for advice from a healthcare professional. Consultation with a healthcare provider is relevant before commencing any new treatment.


Evaluation of Research in Symptom Study

Studies investigated whether treatment was associated with changes in pain and inflammation levels in the joints of participants with Condition X.

  • Primary Studies: Initial Phase II and III trials focused on the short-term impact of Enthusia. These trials primarily observed patient-reported changes over 12 weeks. Specific changes in symptom severity were reported.
  • Long-Term Follow-Up: Research has explored whether long-term use was associated with changes in symptom onset time. The long-term follow-up studies extended observation for up to two years.

Research has examined the role of Enthusia in the study of Condition X symptoms.


Associated Pathways and Combination Research

Studies investigated the potential relationship between Enthusia and pathway Z. This pathway is associated with the study of Condition X progression.

  • Combination Therapies: Furthermore, studies evaluated whether a combined approach (Enthusia + Drug B) was associated with changes in overall prognosis. This was an exploratory analysis.
  • Tolerability in Specific Populations: The combined approach was evaluated for tolerability in elderly patient groups. The study protocol included specific administration conditions.

Observed Safety and Risk Profile

Studies examined the incidence of flare-ups in patients receiving the drug compared to a placebo group over a one-year period.

  • Side Effects Profile: Study participants reported adverse events, including gastrointestinal upset and temporary fatigue. Study monitoring included assessment for liver enzyme elevation.
  • Comparative Analysis: Enthusia was compared to older treatment regimens in clinical trials to evaluate differences in observed safety events.

Key Studies & References Clinical Practice Guideline for the Management of Condition X (2024 Update)

Frequently Asked Questions (FAQ)

Common questions about Enthusia (FAQ)


Q: Can Enthusia be taken with common over-the-counter pain relievers?

Official drug information does not specifically list interactions with common over-the-counter pain relievers such as ibuprofen or acetaminophen. Because regulatory labeling focuses on specific prescription drug combinations, it is generally advisable to inform a healthcare provider or pharmacist of all products you are taking, including non-prescription medications.

Q: Is it safe to drink alcohol while on Enthusia?

Regulatory warnings indicate that Sildenafil (the active ingredient in Enthusia) may interact with alcohol. Since the medication is known to cause vasorelaxation, which can reduce blood pressure, combining it with alcohol may amplify this effect. Official guidance suggests limiting or avoiding alcohol intake due to the potential for additive blood pressure lowering effects.

Q: Do you have to take Enthusia at the exact same time every day?

Whether a precise schedule is required depends on the condition being treated. For intermittent use, the timing is 'as needed.' For conditions requiring scheduled use, such as for pulmonary arterial hypertension (PAH), taking the medicine around the same time each day is generally needed to help maintain consistent drug levels in the body.

Q: What should I do if I miss a dose of Enthusia?

Official guidance for the scheduled use of the medication states that if a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Official guidance states that a double dose should not be taken to make up for the one that was missed.

Q: Is it safe to drive or operate machinery while taking Enthusia?

Official side effect guidance suggests caution when performing activities that require concentration. If common side effects such as dizziness or abnormal vision occur, official guidance suggests avoiding driving or operating machinery until these effects subside.

Q: Are there generic versions of Enthusia available?

Yes, the active ingredient in Enthusia, Sildenafil, is widely available in generic forms. These generic versions are approved by regulatory bodies, such as the FDA, as pharmaceutically equivalent to the branded product.

Q: Does Enthusia cause weight gain or weight loss?

Changes in body weight are not listed as common side effects in the official product information. However, less common adverse event reports have included unusual or rapid weight gain or loss, particularly in patients receiving the intravenous (IV) form of the medication.

Q: Is Enthusia a controlled substance?

No, according to regulatory classification by the U.S. Drug Enforcement Administration (DEA), the active ingredient Sildenafil is formally designated as not a controlled drug (DEA Schedule: None).

Q: Do children or teenagers ever take Enthusia?

The medication is not indicated for individuals under 18 for the treatment of erectile dysfunction. However, it is approved for use in pediatric patients one year and older for Pulmonary Arterial Hypertension (PAH). Regulatory labels indicate that chronic use in children is generally not recommended due to reports of increased mortality at higher doses.

Q: Is Enthusia safe for elderly patients?

Clinical studies did not include sufficient numbers of elderly patients (aged 65 and over) to definitively determine if their response differs. Official labeling recommends that healthcare providers consider a cautious or lower starting dose for these patients, reflecting the greater frequency of decreased liver, kidney, or heart function that can occur with age.

Q: Can Enthusia affect sleep patterns?

Difficulty sleeping, or insomnia, is listed as a potential side effect in some official Sildenafil prescribing information. If changes to sleep patterns are noticed after starting this medication, it is important to discuss this with a healthcare provider.

Q: Will Enthusia interact with birth control pills?

Official guidance states that Sildenafil does not affect the effectiveness of any type of hormonal contraception, including combined pills, progestogen-only pills, or emergency contraceptives.

Q: Is there a risk of dependence or addiction with Enthusia?

The active ingredient in Enthusia is a PDE5 inhibitor and is not considered physically addictive, nor does it cause physical withdrawal symptoms. The focus of regulatory documents is that the drug is not considered physically addictive.

Q: Are there any long-term side effects associated with Enthusia that people worry about?

While most common side effects are transient, the label highlights a few clinically significant serious adverse reactions that have been reported in temporal association with use. These include Priapism (a prolonged erection) and sudden loss of vision or hearing, which are rare but serious concerns.

Q: Can I take multivitamins or supplements while on Enthusia?

Herbal remedies and supplements are not regulated or tested in the same rigorous way as prescription medicines. Official guidance suggests informing a healthcare provider or pharmacist if you are taking any vitamins, herbal products, or supplements to check for potential interactions.

Q: Can Enthusia cause vision changes?

Yes, it is a documented side effect. Abnormal Vision (including blurred vision or color tinge) is listed as common. Sudden vision loss (Non-arteritic Anterior Ischaemic Optic Neuropathy, or NAION) is listed as a rare, serious adverse event that requires prompt medical attention.

Q: Can Enthusia be crushed or split if it's hard to swallow?

Official administration instructions state that the film-coated tablets should be swallowed whole with fluid. Instructions for crushing or splitting the tablets are not typically provided in the product information. Other formulations, such as a liquid suspension, are available for certain indications.

Q: What are some lesser-known but possible interactions with Enthusia?

Official drug interaction sections include specific, less common risks. For patients being treated for Pulmonary Arterial Hypertension (PAH), there has been an association with an increased incidence of nosebleeds (epistaxis) when Sildenafil is co-administered with oral Vitamin K Antagonists (blood thinners like Warfarin).

Q: Does Enthusia have any impact on focus or concentration?

Dizziness is listed as a common side effect of the medication. This central nervous system (CNS) effect may indirectly affect focus and concentration, potentially impacting activities such as driving.

Q: What happens if you take Enthusia with caffeine?

The official product label does not specifically address caffeine consumption. Moderate intake is generally not known to affect how Sildenafil works. However, high intake of caffeine, especially from energy drinks, may have additive effects on the heart rate and blood pressure, potentially increasing common side effects like headaches.

Q: Can Enthusia affect a person's libido or sexual function?

The medication is approved to treat Erectile Dysfunction (ED) by improving the physical component of blood flow. Official product information focuses on the drug’s physical effects and does not typically address the psychological component of libido (sexual desire) itself.

Q: What should I tell a new doctor about my Enthusia prescription?

It is important for a patient to inform any new healthcare provider about their use of Enthusia. Key information to disclose includes any history of low blood pressure, recent heart attack or stroke, pre-existing vision or hearing problems, or if any nitrates or blood pressure lowering medications are being taken.

Q: Are there specific symptoms that signal an urgent side effect reaction to Enthusia?

Yes, certain reactions require immediate emergency medical attention. Urgent symptoms include an erection lasting more than four hours (Priapism), sudden loss of vision in one or both eyes, or a sudden decrease or complete loss of hearing, all of which require prompt medical attention.

Q: Can Enthusia cause dry mouth or constipation?

Dry mouth is listed as a potential side effect in some official drug information, but it is not among the most common adverse events. Constipation is not typically listed as a common side effect of the medication.

Q: Can Enthusia be taken during pregnancy or breastfeeding?

Regarding pregnancy, limited published data has not reported a clear association between Sildenafil and adverse fetal outcomes, though the underlying condition (PAH) itself poses risks. Sildenafil and its active metabolite are known to pass into human milk, but official label information states there is insufficient data to determine the effects on the breastfed infant.

How should Enthusia be stored and disposed of?

Storage and Disposal Requirements

Enthusia must be stored at controlled room temperature, generally between 20 C and 25 C (68 F and 77 F), with excursions up to 30 C permitted. The container must be kept securely sealed. As an officially controlled substance, it is mandatory to store Enthusia in a securely locked cabinet or safe that is inaccessible to the public. It is essential to keep the product out of the reach of children.

Once a multi-dose vial is first opened, it must be discarded after 28 days to maintain stability. Used or expired Enthusia must not be disposed of in household trash or down the sink. Disposal requires following specific regulatory guidelines, typically involving drug take-back programs or rendering the product unretrievable through documented destruction methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Enthusia found in:

A-Z Index: